CJC-1295 (with DAC)

CJC-1295 — Advanced Growth Hormone Releasing Peptide

CJC-1295 is a synthetic analogue of growth hormone-releasing hormone (GHRH) engineered for extended half-life and sustained bioactivity. Designed for research applications, it demonstrates a strong affinity for binding to GHRH receptors, making it a widely studied compound in the fields of endocrinology and metabolic research.

Key Research Characteristics

• Extended Half-Life: CJC-1295 (with DAC) exhibits a half-life of up to 8 days, enabling sustained plasma GH and IGF-1 elevation in research models
• High Purity: Synthesized to ≥98% purity via HPLC verification — Certificate of Analysis (COA) available upon request
• Mechanism: Binds to GHRH receptors on somatotroph cells of the anterior pituitary, stimulating GH secretion in a pulsatile, physiologically relevant manner
• Research Applications: Studied in the context of GH deficiency models, body composition research, and metabolic function studies

Product Specifications

• Sequence: Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH₂
• Molecular Formula: C₁₅₂H₂₅₂N₄₂O₄₂
• Molecular Weight: ~3367.9 Da
• Form: Lyophilized powder
• Storage: Store at -20°C; stable for 24 months when properly stored

For research purposes only. Not intended for human or veterinary use. This product is sold strictly for in vitro and laboratory research.